Related Experiment Video
Updated: Nov 17, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
Selective Cytotoxicity of Piperine Over Multidrug Resistance Leukemic Cells
Julia Quarti1,2, Daianne N M Torres3, Erika Ferreira2
1Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Piperine, a compound from black pepper, selectively targets drug-resistant chronic myeloid leukemia (CML) cells, inducing collateral sensitivity (CS). This suggests a potential new therapeutic strategy for overcoming multidrug resistance (MDR) in CML treatment.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Multidrug resistance (MDR) poses a significant challenge in treating chronic myeloid leukemia (CML).
- P-glycoprotein (P-gp) overexpression is a key mechanism driving MDR in CML.
- Collateral sensitivity (CS) offers a potential strategy to overcome MDR by selectively targeting resistant cells.
Purpose of the Study:
- To investigate the effect of piperine on inducing CS in CML MDR cells.
- To elucidate the mechanisms underlying piperine-induced CS, including P-gp dependence and potential involvement of PARP-1.
Main Methods:
- Cytotoxicity assays (metabolic activity, viability, cell morphology, apoptosis) were performed on K562 parental cells and K562-derived MDR cells (Lucena-1, FEPS).
- The role of P-gp in CS induction was assessed.
- The involvement of poly (ADP-ribose) polymerase-1 (PARP-1) was investigated by analyzing the 24 kDa fragment levels in MDR cells.
Main Results:
- Piperine demonstrated increased cytotoxicity towards CML MDR cells (Lucena-1, FEPS) compared to the parental K562 cells, confirming CS induction.
- CS induction was partially dependent on P-gp.
- Piperine reduced the levels of the 24 kDa PARP-1 fragment in MDR FEPS cells, suggesting a P-gp independent mechanism.
Conclusions:
- Piperine selectively induces collateral sensitivity in CML MDR cells.
- The mechanism of piperine-induced CS may involve both P-gp dependent and independent pathways, including modulation of PARP-1.
- Piperine represents a promising agent for targeting MDR in CML.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers

